Replies to post #173819 on Biotech Values

[DewDiligence]

AGN’s Botox sold at a $2.1B annualized rate in 4Q13, +12% YoY in constant currencies:

http://finance.yahoo.com/news/allergan-reports-fourth-quarter-2013-140000310.html

Medical (i.e. non-cosmetic) Botox indications accounted for 54% of total Botox sales in 2013 and grew faster than Botox sales in cosmetic indications.

AGN’s 2014 guidance calls for Botox sales of $2.18-2.28B and non-GAAP EPS of $1.09-1.12.